Zoledronic acid 4 mg

DRUG4 trials

Sponsors

Novartis Pharmaceuticals, GlaxoSmithKline, Assiut University, University of Aarhus

Conditions

Fractures, BoneNon-Small-Cell Lung CancerPrimary HyperparathyroidismUse of Zoledronic Acid in Breast Cancer

Phase 3

A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)

CompletedNCT00172042

Novartis PharmaceuticalsNon-Small-Cell Lung Cancer

Start: 2005-03-31End: 2010-06-30Updated: 2015-05-04

A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors

CompletedNCT01920568

GlaxoSmithKlineFractures, Bone

Start: 2013-08-31End: 2016-04-30Updated: 2017-01-16

Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

Assiut UniversityUse of Zoledronic Acid in Breast Cancer

Start: 2021-09-30End: 2023-09-30Target: 50Updated: 2021-12-21

Phase 4

Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism

RecruitingNCT06859580

University of AarhusPrimary Hyperparathyroidism

Start: 2025-03-01End: 2028-02-01Target: 140Updated: 2025-03-25

Related Papers

Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose denosumab in healthy Chinese volunteers: A randomized, single-blind, placebo-controlled study

PLoS ONE2018-06-2240 citations

Efficacy and safety of denosumab from a phase III, randomized, active-controlled study compared with zoledronic acid in patients of Asian ancestry with bone metastases from solid tumors.

Journal of Clinical Oncology2016-05-206 citations